1. Home
  2. MAX vs TECX Comparison

MAX vs TECX Comparison

Compare MAX & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MediaAlpha Inc.

MAX

MediaAlpha Inc.

HOLD

Current Price

$12.44

Market Cap

563.7M

Sector

Industrials

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$21.05

Market Cap

618.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAX
TECX
Founded
2014
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
563.7M
618.9M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
MAX
TECX
Price
$12.44
$21.05
Analyst Decision
Buy
Strong Buy
Analyst Count
8
10
Target Price
$14.50
★ $71.00
AVG Volume (30 Days)
★ 905.3K
222.1K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
25.81
★ 40.70
EPS
★ 0.86
N/A
Revenue
★ $1,113,600,000.00
N/A
Revenue This Year
$18.87
N/A
Revenue Next Year
$8.14
N/A
P/E Ratio
$13.38
★ N/A
Revenue Growth
★ 28.78
N/A
52 Week Low
$7.09
$15.60
52 Week High
$14.70
$39.53

Technical Indicators

Market Signals
Indicator
MAX
TECX
Relative Strength Index (RSI) 66.01 33.35
Support Level $11.73 $20.52
Resistance Level $14.42 $23.61
Average True Range (ATR) 0.57 1.13
MACD 0.31 0.23
Stochastic Oscillator 99.32 18.59

Price Performance

Historical Comparison
MAX
TECX

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that enables insurance carriers and distributors to target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It serves as a customer acquisition channel in property and casualty insurance, health insurance, and life insurance. The company operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: